Aurora Cannabis Exceeds 3,000 Active Registered Patients in Five Months
Production, Inventory and Customer Care Meeting Rising Demand
VANCOUVER, BRITISH COLUMBIA–(Marketwired – May 30, 2016) – Aurora Cannabis Inc. (cse:ACB)(frankfurt:21P)(wkn:A1C4WM)(otcqb:ACBFF) (“Aurora” or the “Company”), announced that the Company has exceeded 3,000 active registered patients over the first five months since commencement of product sales on January 5, 2016. Management believes this is the fastest organic rate of growth in patient registration that any Licensed Producer has achieved, and will help the Company towards reaching profitability in record time.
The Company previously announced on March 31, 2016 that it had registered 1,000 patients in its first three months of product sales, and on May 9, 2016 that it had surpassed 2,000 patients over its first four months of sales.
Aurora’s pace of patient acquisition is unprecedented in the industry, and has exceeded our expectations. We had optimistically